Harvard Bioscience, Inc. (HBIO) Stock Overview
Explore Harvard Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Harvard Bioscience, Inc. (HBIO)
Key Financials
Key Financials
Market Cap
27.7M
P/E Ratio
-2.79
EPS (TTM)
$-0.36
ROE
-0.73%
HBIO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Harvard Bioscience, Inc. (HBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 52.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.17.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.79 and a market capitalization of 27.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.